AI tool for diagnosing basal cell carcinoma
Part of Cancer clinical trials.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a skin biopsy that was already confirmed to be basal cell carcinoma (BCC).
- Your biopsy slide must be well-stained and well-preserved so the tissue details are clear.
- The slide must not be damaged, faded, or have any defects that could interfere with viewing it under a microscope.
- The original diagnosis must have been clear and certain, not uncertain or inconclusive.
- The slide must be in a condition that can be successfully converted into a digital image for computer analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help diagnose seborrheic keratosis, a common harmless skin growth. It aims to see if the AI can accurately identify these growths from skin samples, which could help doctors make faster and more reliable diagnoses.
This study uses artificial intelligence (AI) to look at skin biopsy slides from people with mycosis fungoides, a type of skin lymphoma. The goal is to see if AI can help doctors diagnose this condition more accurately, which could lead to better and earlier treatment.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This study tests an AI-enhanced imaging technique to help doctors see the edges of a common type of skin cancer called basal cell carcinoma before surgery. It may help ensure the cancer is removed completely the first time.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
Hear when a new Basal Cell Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.